SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
ADP entered into two new revolving credit facilities totaling $9.2 billion ($5.7 billion 364-Day Facility and $3.5 billion Five-Year Facility) on June 26, 2026, replacing prior facilities of similar size. The syndicated facilities with major lenders (JPMorgan, Bank of America, BNP Paribas, Wells Fargo, Deutsche Bank) constitute material new direct financial obligations.
View raw filing on EDGAR →This disclosure announces the conclusion of a legal review initiated following Mr. Atanu Chakraborty's resignation as an executive officer. The external law firms (Wilson Sonsini and Wadia Ghandy) conducted a three-month investigation into concerns raised in his resignation letter and found his allegations unsubstantiated. While the resignation itself occurred earlier (March 24, 2026), this announcement of the legal review's outcome is a governance event addressing the integrity of board processes and management conduct — material to investors assessing the bank's governance and leadership credibility.
View raw filing on EDGAR →Zentek has formed Strategic Graphite Partners LLC, a joint venture with ALO Graphite Partners LLC, in which Zentek USA Inc. holds 90% ownership and ALO Partners holds 10%. This constitutes entry into a material joint venture arrangement designed to establish a U.S. footprint for Zentek's Albany ultra-high-purity graphite in energy, defense, and national-security markets. The JV structure, governance, and strategic purpose to access federal and allied government funding programs represent a material change in the company's capital structure and market positioning.
View raw filing on EDGAR →This is a voting results report filed pursuant to National Instrument 51-102 disclosing the outcomes of Trekor Metals Limited's annual general meeting held on June 24, 2026. The exhibit presents detailed voting tallies for six items: auditor appointment (99.43% in favor), director count (98.70% in favor), election of nine directors (ranging from 73.8% to 99.2% in favor), name change approval (95.57% in favor), plan amendments (70.16% in favor), and say-on-pay advisory vote (96.20% in favor). This is a classic shareholder_vote_results disclosure documenting the formal outcomes of shareholder votes at an annual meeting.
View raw filing on EDGAR →Energy Fuels Inc. entered into a definitive merger agreement on June 23, 2026, to acquire the Ara VAC entities for aggregate consideration of $718 million in cash, 65.853 million common shares, and potentially preferred shares up to $135 million, subject to customary closing conditions including HSR Act approval.
View raw filing on EDGAR →Energy Fuels Inc. entered into a Senior Secured Term Loan Commitment Letter as part of the financing for the Ara VAC acquisition, creating a material direct financial obligation.
View raw filing on EDGAR →Energy Fuels Inc. held its 2026 annual meeting of shareholders on June 24, 2026, with voting results reported on four proposals: election of seven directors, appointment of KPMG LLP as auditors, a Say-on-Pay advisory vote, and a Say-When-On-Pay advisory vote.
View raw filing on EDGAR →Energy Fuels Inc. received a conditional $725 million financing commitment from the U.S. Department of War's Office of Strategic Capital for a 20-year loan to support expansion of critical minerals processing and rare earth metals facilities.
View raw filing on EDGAR →The filing discloses an increase in the amount available for sale under an At The Market (ATM) Offering Agreement by an additional $15,000,000 of common shares. The Company has already sold 1,804,444 shares for approximately $12.66 million since May 2024, and this new authorization substantially expands the dilutive issuance capacity. ATM offerings are classic dilutive equity issuances that signal capital-raising activity and shareholder dilution, particularly material for a small-cap company like Ascent Solar with only 9.8 million shares outstanding as of the filing date.
View raw filing on EDGAR →The filing's primary disclosure is the appointment of Joseph R. Hinrichs as a director and expected future Chair of the Board, effective June 25, 2026. While the Item 5.02 section also covers compensatory arrangements (director compensation, CEO salary/equity increases, and adoption of new compensation plans), the salient event centers on the executive appointment. The appointment of an independent director with audit committee expertise to lead the board of a newly spun-off company is material to investors assessing governance and leadership continuity post-separation.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the final voting results from SmartKem's Annual Meeting of Stockholders held on June 23, 2026. The filing presents detailed vote tallies for all eleven proposals submitted to shareholders, including director elections, executive compensation advisory votes, auditor ratification, and multiple charter amendments. The disclosure of shareholder vote results is material as it reflects stockholder approval of significant corporate actions including authorization increases and governance changes.
View raw filing on EDGAR →The exhibit announces voting results from H World's 2026 Annual General Meeting held on June 26, 2026. It discloses passage of four ordinary resolutions: ratification of Deloitte as auditor, re-election of Justin Martin Leverenz as director, re-election of Yi Zhang as independent director and audit committee chairwoman, and authorization for implementation actions. This is a classic shareholder_vote_results disclosure reporting outcomes of an annual meeting vote.
View raw filing on EDGAR →The exhibit announces a US$20 million share repurchase program approved by the Board, effective July 1, 2026. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which explicitly includes "share-repurchase programs." The program is material as it represents a significant commitment of the company's cash resources (approximately 6.6% of the US$303.6 million cash balance as of March 31, 2026) and signals management confidence in the company's valuation and operational performance.
View raw filing on EDGAR →The disclosure announces FDA acceptance of a Biologics License Application (BLA) resubmission for RP1 in advanced melanoma with an expedited review timeline (decision expected by August 2, 2026) and an advisory committee meeting planned. This is a material regulatory milestone for a clinical-stage biotech company's lead product candidate, but it does not fit the specific event types of earnings release, M&A activity, impairment, or other defined categories. It is clearly operational/strategic in nature—a significant product development and regulatory advancement event.
View raw filing on EDGAR →This exhibit discloses the poll results of Hesai Group's Annual General Meeting held on June 26, 2026, including voting outcomes on seven ordinary resolutions covering financial statement adoption, director re-elections, auditor re-appointment, share issuance and repurchase mandates, and a material share subdivision (8-for-1 split effective July 10, 2026). The detailed voting tallies by share class and the passage of all resolutions constitute a shareholder_vote_results disclosure. The share subdivision is material to investors as it affects share structure and trading arrangements.
View raw filing on EDGAR →Celldex held its Annual Meeting of Stockholders on June 25, 2026, with shareholders voting on four proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as auditor, approval of an amendment to the 2021 Omnibus Equity Incentive Plan increasing available shares by 3.4 million, and advisory approval of named executive officer compensation. All proposals received tabulated voting results.
View raw filing on EDGAR →Southern Peru Copper Corporation (SPCC), a subsidiary of Southern Copper Corporation, issued US$1.25 billion in bonds through a New York market offering with a 5.35% annual interest rate maturing in 2036. This represents a material creation of direct financial obligation for the registrant and its subsidiary, disclosed under Item 8.01 as a press release announcement of the completed bond offering.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of CION's Annual Meeting of Shareholders held on June 25, 2026, including voting outcomes for two proposals: election of two board directors (Robert A. Breakstone and Catherine K. Choi) and ratification of RSM US LLP as independent auditor. The filing provides detailed vote tallies (votes for, withheld, against, abstentions, and broker non-votes) for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →The filing discloses the convening and adjournment of an extraordinary general meeting on June 26, 2026, where shareholders voted to approve an adjournment of the meeting to allow for a reconvened vote on a proposal to extend the date by which the Company must consummate an initial business combination. While the final vote on the Extension itself has not yet occurred (scheduled for the reconvened meeting at 3:00 p.m. the same day), the disclosure of the shareholders' approval of the adjournment proposal constitutes a shareholder vote result material to investors assessing the Company's timeline for completing its business combination.
View raw filing on EDGAR →SmartKem funded a $2.5 million convertible promissory note to Ferrox on June 22, 2026, creating a direct financial obligation with 5% interest, maturity on December 31, 2026, and conversion rights into Ferrox ordinary shares.
View raw filing on EDGAR →SmartKem issued 5,000 shares of Series A convertible preferred stock and 10,753,615 warrants in a private placement on June 22, 2026, raising approximately $4.0 million in cash under Section 4(a)(2) and Regulation D Rule 506.
View raw filing on EDGAR →Soligenix increased the maximum aggregate offering amount under an At Market Issuance Sales Agreement (ATM offering) by an additional $2,500,000 of common stock. The company had previously sold approximately $6,234,000 under the same agreement. ATM offerings are a classic form of dilutive equity issuance used by smaller public companies to raise capital, and the prospectus supplement filing establishes the legal framework for this dilutive offering.
View raw filing on EDGAR →The filing discloses multiple compensatory arrangements approved by the HRCC effective June 24, 2026: (1) a TY26 annual cash incentive plan with target payouts ranging from 100–175% of base salary for six named executive officers; (2) a TY26–CY28 long-term equity program comprising PSUs and RSUs with target payouts of 200–450% of base salary; (3) Spin-Off bonuses (cash and RSUs) totaling up to $1 million for Mr. Smith; and (4) an Equity-Based Retirement Policy governing vesting treatment. These are core executive compensation matters within the scope of Item 5.02(e).
View raw filing on EDGAR →Ronald L. Sargent transitioned from Chief Executive Officer to Non-Executive Chairman with a new compensatory arrangement consisting of an annual retainer of $115,000 and incentive share grants valued at approximately $250,000.
View raw filing on EDGAR →Kroger held its 2026 Annual Meeting of Shareholders on June 25, 2026, with shareholders voting on director elections (ten directors elected), advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as independent auditor, approval of the Second Amended and Restated 2019 Long-Term Incentive Plan, and rejection of a shareholder proposal on GHG emissions reductions.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Navitas Semiconductor's 2026 annual meeting of stockholders held on June 25, 2026, including voting outcomes on four proposals: election of three directors, declassification of the board (which failed), advisory approval of executive compensation, and ratification of KPMG LLP as auditor. The filing directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders.
View raw filing on EDGAR →HA Sustainable Infrastructure Capital, Inc. issued $1,000,000,000 aggregate principal amount of 5.950% green senior unsecured notes due 2033 under an indenture dated June 24, 2026. This material debt issuance represents a significant capital-raising event and direct financial obligation.
View raw filing on EDGAR →The filing discloses termination of a material business combination agreement between Israel Acquisitions Corp and Gadfin Ltd., originally entered into on January 26, 2025, and terminated on June 22, 2026. The agreement contemplated a series of merger transactions that would have resulted in both parties becoming wholly owned subsidiaries of a newly formed Israeli holding company. Termination of a material definitive agreement governing a proposed merger or acquisition is a core M&A activity event under Item 1.02.
View raw filing on EDGAR →The 6-K discloses the results of Polestar's 2026 annual general meeting held on June 26, 2026, including voting outcomes on 16 resolutions covering financial statement approval, director re-appointments, auditor appointment (PwC replacing Deloitte AB), remuneration policies, and share issuance authorities. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, with detailed vote tallies and outcomes. The auditor change (Deloitte AB to PwC) is material but is disclosed as part of the AGM voting results rather than as a standalone auditor_change event.
View raw filing on EDGAR →Cboe Global Markets entered into an Amendment and Restatement Agreement on June 23, 2026, to amend and restate a credit facility originally dated July 1, 2020, with an aggregate commitment of €1.2 billion (expandable to €1.7 billion via accordion increase) and an extended term to June 25, 2027. This material amendment to the Company's direct financial obligations constitutes a significant modification to its credit arrangements.
View raw filing on EDGAR →The filing discloses the appointment of Michael L. Hammer to the Board of Directors of URSB Bancorp, Inc. and its bank subsidiary, effective July 29, 2026, with assignment to the Audit Committee and Nominating/Corporate Governance Committee. This is a clear executive appointment under Item 5.02, and board appointments are material to investors as they affect governance and oversight.
View raw filing on EDGAR →The filing discloses the issuance of $300,000,000 aggregate principal amount of 4.400% Fixed Rate Senior Notes due June 15, 2029, by John Deere Capital Corporation on June 26, 2026, pursuant to an automatic shelf registration statement. This is a material creation of a direct financial obligation and constitutes a debt issuance event.
View raw filing on EDGAR →The announcement discloses a material amendment to the Brasília Airport concession agreement, including replacement of the fee structure, exit of a co-shareholder (Infraero), addition of 10 regional airports, and a mandatory competitive tender process for 100% of Inframerica shares by December 2026. These constitute material changes to the economic terms and control structure of a significant asset, triggering a potential change-of-control event through the required public tender process.
View raw filing on EDGAR →Iron Mountain completed a private offering of $1.5 billion in 6.250% Senior Notes due 2035 on June 26, 2026, under a new indenture with Computershare Trust Company N.A. as trustee. Net proceeds of approximately $1.48 billion will be used to repay revolving credit facility borrowings and for general corporate purposes, representing a significant capital structure event.
View raw filing on EDGAR →The filing discloses entry into a material definitive agreement for the sale of substantially all of the Company's assets. On June 22, 2026, Charles & Colvard entered into an Asset Purchase Agreement (the "AJS Purchase Agreement") with AJS Creations, Inc., whereby AJS agreed to acquire the Company's specified assets and assume certain liabilities for $2,700,000 in cash, subject to Bankruptcy Court approval (which was granted on June 25, 2026). This constitutes a material acquisition/disposition transaction under Item 1.01, representing a fundamental change in the Company's structure and operations during its Chapter 11 bankruptcy proceeding.
View raw filing on EDGAR →Union Electric Company (Ameren Missouri) filed a $343 million annual revenue increase request with the Missouri Public Service Commission on June 26, 2026. This is a material regulatory filing involving rate base of $16.7 billion and requested return on equity of 10.25%, which would directly affect the company's future cash flows and earnings. While regulatory proceedings are operational/strategic in nature, this does not fit the specific categories of debt issuance, dividend distribution, workforce reduction, or material litigation—it is a significant regulatory capital recovery request that a reasonable investor would consider material to assessing the company's financial prospects.
View raw filing on EDGAR →Daniel Bendheim's appointment to Chief Executive Officer and President effective July 1, 2026 is the principal disclosed action. While the filing also details compensatory arrangements (employment agreement with $850,000 base salary, bonus, RSU grants), the core event is the executive appointment to the top leadership role. This is material to investors as CEO appointments significantly affect company direction and governance.
View raw filing on EDGAR →Capricor announced that the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee will convene on July 29, 2026 to review the company's Biologics License Application (BLA) for Deramiocel, with a PDUFA target action date of August 22, 2026. This is a material regulatory milestone in the development of the company's lead product candidate for Duchenne muscular dystrophy, representing a significant step toward potential FDA approval. While not a completed approval or a specific operational event like a partnership or contract, this is a material regulatory development that would affect investor assessment of the company's near-term prospects.
View raw filing on EDGAR →Shareholders of SELECT MEDICAL HOLDINGS CORP voted on June 26, 2026 to approve the Merger Proposal to adopt the Agreement and Plan of Merger with Stallion Intermediate Corporation and Stallion MergerSub Corporation, with 99,005,011 votes in favor and 1,789,017 against, representing approval by over 79.88% of outstanding shares and over 76.64% of unaffiliated shares. The vote also addressed a non-binding advisory Compensation Proposal (52,322,733 for, 48,410,193 against) and an Adjournment Proposal (rendered moot).
View raw filing on EDGAR →Graf Global Corp. entered into non-redemption agreements with shareholders on June 26, 2026, in connection with a proposed business combination with BIG3 HoldCo LLC. The Sponsor agreed to transfer 425,602 Founder Shares to non-redeeming shareholders to incentivize non-redemptions and preserve capital for the transaction's consummation.
View raw filing on EDGAR →Shareholders approved two proposals at a meeting held on June 26, 2026: (i) an Extension Amendment extending the initial business combination deadline from June 27, 2026 to September 27, 2026, with further discretionary extensions possible, and (ii) an Adjournment Proposal. The Extension Amendment received 21,123,642 votes in favor and 1,619,105 votes against.
View raw filing on EDGAR →The filing discloses a delisting notice under Item 3.01. Although the Company ultimately regained compliance with Nasdaq's minimum bid price rule (Listing Rule 5550(a)(2)) and the delisting matter is now closed as of June 26, 2026, the disclosure documents the Company's prior failure to maintain the $1.00 minimum bid price for 30 consecutive business days (triggering the February 18, 2026 delisting notice) and its subsequent remediation. This is a material event affecting the registrant's listing status and investor confidence, even though the immediate delisting risk has been resolved.
View raw filing on EDGAR →The disclosure centers on compensatory arrangements for Jim Stephens, the Company's President of Cardiac Rhythm Management & Neuromodulation, including approval by the Compensation and Organization Committee of changes to his compensation in connection with a role transition to Executive Vice President, Special Projects, effective June 29, 2026, with a termination date of March 31, 2027, and exclusion from short-term and long-term incentive awards in 2027. While the filing also involves a role change, the principal disclosed action and the Committee's formal approval focus on the compensation modifications and severance-related terms (including the conditional "termination without Cause" treatment under the Change of Control Agreement), making this primarily a compensatory arrangement disclosure under Item 5.02(e).
View raw filing on EDGAR →ProAssurance completed a merger in which Merger Sub merged with and into ProAssurance, with ProAssurance becoming a wholly owned subsidiary of The Doctors Company. ProAssurance shareholders received $25.00 per share in cash consideration, with all equity awards converted to cash payments at the same rate.
View raw filing on EDGAR →ProAssurance notified the NYSE on June 26, 2026 of the completion of the merger and requested suspension of trading and delisting of its common stock from the NYSE via Form 25 filing. The company intends to file Form 15 to terminate registration under Section 12(g) and suspend reporting obligations.
View raw filing on EDGAR →ProAssurance disclosed a material modification to the rights of security holders by cross-reference to Items 2.01, 3.01, 5.01, and 5.03, relating to the merger completion, delisting, change of control, and governance amendments.
View raw filing on EDGAR →The 6-K discloses results of GH Research PLC's annual general meeting held on June 25, 2026, where shareholders voted on and passed all board-recommended resolutions, including re-election of four directors (Florian Schönharting, Michael Forer, Dermot Hanley, and Duncan Moore) and ratification of PricewaterhouseCoopers Ireland as independent auditors. This is a classic shareholder vote result disclosure under Item 5.07 equivalent for foreign private issuers.
View raw filing on EDGAR →BridgeBio held its Annual Meeting on June 22, 2026, with shareholders voting on five proposals: election of three Class I directors (James C. Momtazee, Frank P. McCormick, and Hannah A. Valantine), advisory approval of named executive officer compensation, annual frequency of say-on-pay votes, ratification of Deloitte & Touche LLP as independent auditor, and approval of an amendment to the 2021 Stock Option and Incentive Plan increasing reserved shares by 2,000,000.
View raw filing on EDGAR →Ioneer received a conditional award from the U.S. Army for a long-term land lease at Tooele Army Depot to establish a critical mineral processing facility for boron. This is a material strategic partnership and operational milestone—one of only four companies selected—that secures a domestic supply chain for a critical mineral essential to national defense. While not a traditional M&A transaction, debt issuance, or earnings event, this represents a significant operational and commercial development that would affect a reasonable investor's assessment of the company's growth prospects and strategic positioning.
View raw filing on EDGAR →VeriSign entered into an underwriting agreement on June 18, 2026 to issue $550 million aggregate principal amount of 5.100% Senior Notes due 2031. This is a direct creation of a new financial obligation through a registered debt offering, with net proceeds of approximately $545 million expected to be used to redeem existing 4.750% Senior Notes due 2027. The disclosure of the underwriting agreement, registration statement, and indenture documents clearly indicates a material debt issuance event.
View raw filing on EDGAR →